Leerink Partnrs Expects Reduced Earnings for Teladoc Health

Teladoc Health, Inc. (NYSE:TDOC) – Investment analysts at Leerink Partnrs reduced their Q4 2024 earnings per share estimates for shares of Teladoc Health in a note issued to investors on Wednesday, October 30th. Leerink Partnrs analyst M. Cherny now anticipates that the health services provider will post earnings of ($0.19) per share for the quarter, down from their prior estimate of ($0.15). The consensus estimate for Teladoc Health’s current full-year earnings is ($1.19) per share. Leerink Partnrs also issued estimates for Teladoc Health’s Q4 2025 earnings at ($0.23) EPS, FY2025 earnings at ($1.09) EPS, FY2026 earnings at ($0.83) EPS and FY2027 earnings at ($0.65) EPS.

A number of other analysts have also issued reports on the company. Barclays lifted their price target on Teladoc Health from $10.00 to $12.00 and gave the stock an “overweight” rating in a research note on Thursday, October 31st. TD Cowen lowered their price objective on shares of Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a research note on Thursday, October 31st. DA Davidson lowered their price objective on Teladoc Health from $12.00 to $8.00 and set a “neutral” rating for the company in a research report on Thursday, August 1st. Oppenheimer lowered their price target on Teladoc Health from $21.00 to $17.00 and set an “outperform” rating for the company in a report on Thursday, August 1st. Finally, Jefferies Financial Group raised their price objective on Teladoc Health from $8.00 to $10.00 and gave the stock a “hold” rating in a report on Tuesday, September 17th. Fourteen investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, Teladoc Health presently has an average rating of “Hold” and a consensus target price of $11.97.

Teladoc Health Stock Up 3.1 %

TDOC opened at $9.15 on Monday. The stock has a market capitalization of $1.57 billion, a price-to-earnings ratio of -1.58 and a beta of 0.90. Teladoc Health has a fifty-two week low of $6.76 and a fifty-two week high of $22.54. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The company has a fifty day moving average of $8.51 and a two-hundred day moving average of $9.61.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share for the quarter, topping the consensus estimate of ($0.29) by $0.10. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The company had revenue of $640.51 million for the quarter, compared to the consensus estimate of $630.50 million.

Insider Buying and Selling

In other Teladoc Health news, CFO Mala Murthy sold 8,750 shares of the firm’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $7.16, for a total transaction of $62,650.00. Following the completion of the transaction, the chief financial officer now directly owns 85,767 shares in the company, valued at approximately $614,091.72. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, CFO Mala Murthy sold 8,750 shares of the business’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $7.16, for a total value of $62,650.00. Following the completion of the transaction, the chief financial officer now owns 85,767 shares of the company’s stock, valued at approximately $614,091.72. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, COO Michael Willem Waters sold 4,218 shares of Teladoc Health stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $7.16, for a total value of $30,200.88. Following the completion of the sale, the chief operating officer now owns 78,309 shares of the company’s stock, valued at $560,692.44. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 20,051 shares of company stock valued at $143,565. 0.95% of the stock is owned by insiders.

Hedge Funds Weigh In On Teladoc Health

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Allspring Global Investments Holdings LLC boosted its stake in Teladoc Health by 74.0% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 20,568 shares of the health services provider’s stock valued at $311,000 after acquiring an additional 8,750 shares during the last quarter. Principal Financial Group Inc. grew its position in shares of Teladoc Health by 33.1% during the 1st quarter. Principal Financial Group Inc. now owns 13,833 shares of the health services provider’s stock valued at $209,000 after buying an additional 3,442 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its stake in Teladoc Health by 40.8% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 209,689 shares of the health services provider’s stock valued at $3,166,000 after acquiring an additional 60,780 shares during the period. Janney Montgomery Scott LLC grew its holdings in shares of Teladoc Health by 188.7% during the first quarter. Janney Montgomery Scott LLC now owns 31,594 shares of the health services provider’s stock valued at $477,000 after purchasing an additional 20,651 shares during the last quarter. Finally, Capstone Investment Advisors LLC raised its position in shares of Teladoc Health by 44.8% during the 1st quarter. Capstone Investment Advisors LLC now owns 32,196 shares of the health services provider’s stock worth $486,000 after purchasing an additional 9,968 shares during the period. 76.82% of the stock is owned by institutional investors and hedge funds.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.